Genetically Engineered Cell Lines: Characterisation and Applications in Toxicity Testing

Anon. (1994). ECVAM News & Views. ATLA 22, 7–11.

Doehmer J. , and Greim H. (1993). Cytochrome P450 in genetically engineered cell cultures, the gene technological approach. In Handbook of Experimental Pharmacology, Volume 105, Cytochrome P450 (ed. Schenkman J.B. , Greim H. ), pp. 415–429. Berlin: Springer Verlag.

Waterman M.R. , and Johnson E.F. (1991). Methods in Enzymology, Vol. 206, Cytrochrome P450, 716 pp. New York: Academic Press.

Hornhardt S. , and Wiebel F.J. (1996). Catalogue of Cell Lines in Toxicology & Pharmacology (GSF Bericht No. 3), 249 pp. Neuherberg, Germany: GSF.

Crespi C.L. (1995). Xenobiotic-metabolizing human cells as tools for pharmacological and toxicological research. Advances in Drug Research 26, 179–235.

Sugden B. , Marsh K. , and Yates J. (1985). A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus. Molecular and Cellular Biology 5, 410–413.

Doehmer J. , Wölfel C. , Dogra S. , Doehmer C. , Seidel A. , Platt K.L. , Oesch F. , and Glatt H.R. (1992). Applications of stable V79–derived cell lines expressing rat cytochromes P4501A1, 1A2, and 2B1. Xenobiotica 22, 1093–1099.

Miller A.D. , and Rosman G.J. (1989). Improved retroviral vectors for gene transfer and expression. BioTechniques 7, 980–990.

Dai Y. , Rashba-Step J. , and Cederbaum A.I. (1993). Stable expression of human cytochrome P4502E1 in Hep G2 cells: characterization of catalytic activities and production of reactive oxygen intermediates. Biochemistry 32, 6928–6937.

De Groene E.M. , Hassing I.G.A.M. , Blom M.J. , Seinen W. , Fink-Gremmels J. , and Horbadi G.J. (1996). Development of human cytochrome P450 expressing cell lines: application in mutagenicity testing of ochratoxin-A. Cancer Research 56, 299–304.

Mace K. , Gonzalez F.J. , McConnell I.R. , Garner R.C. , Avanti O. , Harris C.C. , and Pfeifer A.M.A. (1994). Activation of promutagens in a human bronchial epithelial cell line stably expressing human cytochrome P4501A2. Molecular Carcinogenesis 11, 65–73.

Nouso K. , Thorgeisson S.S. , and Battula N. (1992). Stable expression of human cytochrome P4502E1 in mammalian cells: metabolic activation of nitrosodimethylamine and formation of adducts with cellular DNA. Cancer Research 52, 1796–1800.

Salompaa P. , Hakkala J. , Pasanen M. , Pelkonen O. , Vahakas K. , Battula N. , Nouso K. , and Raunio H. (1993). Retrovirus-mediated stable expression of human CYP2A6 in mammalian cells. European Journal of Pharmacology 248, 95–102.

Keown W.A. , Campbell C.R. , and Kucherlapati R.S. (1990). Methods for introducing DNA into mammalian cells. Methods in Emymology 185, 527–537.

Feigner J.H. , Kumar R. , Sridhar C.N. , Wheeler C.J. , Tsai Y.J. , Border R. , Ramsey P. , Martin M. , and Feigner P.L. (1994). Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. Journal of Biological Chemistry 269, 2550–2561.

Mann R. , Mulligen R.C. , and Baltimore D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33, 153–159.

Varmus H.E. (1982). Form and function of retroviral proviruses. Science 216, 812–820.

Crespi C.L. , Langenbach R. , and Penman B.W. (1993). Human cell lines, derived from AHH-1 TK+/- human lymphoblasts, genetically engineered for the expression of cytochromes P450. Toxicology 82, 89–104.

Barnes H.J. , Arlotto M.P. , and Waterman M.R. (1991). Expression and enzymatic activity of recombinant cytochrome P450 17α-hydroxylase in Escherichia coli. Proceedings of the National Academy of Sciences USA 84, 4073–4077.

Renaud J.P. , Peyronneau M.A. , Urban P. , Truan G. , Cullin C. , Pompon D. , Beaune P. , and Mansuy D. (1993). Recombinant yeast in drug metabolism. Toxicology 82, 39–52.

Peyronneau M.A. , Renaud J.P. , Truan G. , Urban P. , Pompon D. , and Mansuy D. (1992). Optimization of yeast-expressed human liver cytochrome P4503A4 catalytic activities by co-expressing NADPH-cytochrome P450 reductase and cytochrome b₅. European Journal of Biochemistry 207, 109–116.

Truan G. , Cullin C. , Reisdorf P. , Urban P. , and Pompon D. (1993). Enhanced in vivo mono-oxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b_s. Gene 125, 49–55.

Pompon D. , Perret A. , Bellamine A. , Laine R. , Gautier J.C. , and Urban P. (1995). Genetically engineered yeast cells and their applications. Toxicology Letters 82–83, 815–822.

Buters J.T.M. , Korzekwa K.R. , Kunze K.L. , Omata Y. , Hardwick J.P. , and Gonzalez F.J. (1994). cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug Metabolism and Disposition 22, 688–692.

Summers M.D. , and Smith G.E. (1987). A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures. Bulletin No. 1555. Texas, USA: Texas Agriculture Experiment Station.

Gonzalez F.J. , Kimura S. , Tamura S. , and Gelboin H.V. (1991). Expression of mammalian cytochrome P450 using baculovirus. Methods in Enzymology 206, 93–99.

Lee C.A. , Kadwell S.H. , Kost TA , & Serabjit-Singh C.J. (1995). CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4. Archives of Biochemistry and Biophysics 319, 157–167.

Zuber M.X. , Simpson E.R. , and Waterman M.R. (1986). Expression of bovine 17α-hydroxylase cytochrome P450 cDNA in non-steroidogenic (COS 1) cells. Science 234, 1258–1261.

Battula N. , Sagara J. , and Gelboin H.V. (1987). Expression of P1-450 and P3-450 DNA coding sequences as enzymatically active cytochromes P450 in mammalian cells. Proceedings of the National Academy of Sciences USA 87, 4790–4793.

Battula N. (1989). Transduction of cytochrome P3-450 by retroviruses: constitutive expression of enzymatically active microsomal hemoprotein in animal cells. Journal of Biological Chemistry 264, 2991–2996.

Crespi C.L. , Gonzalez F.J. , Steimel D.T. , Turner R.T. , Gelboin H.V. , Penman B.W. , and Langenbach R. (1991). A metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chemical Research in Toxicology 4, 566–572.

Crespi C.L. , Penman B.W. , Steimel D.T. , Gelboin H.V. , and Gonzalez F.J. (1991). The development of a human cell line stably expressing human CYP3A4: role in the metabolic activation of aflatoxin B1 and comparison to CYP1A2 and CYP2A3. Carcinogenesis 12, 355–359.

Aoyama T. , Korzekwa K. , Nagata K. , Gillette J. , Gelboin H.V. , and Gonzalez F.J. (1989). cDNA-directed expression of rat testosterone 7α-hydroxylase using the modified Vaccinia virus T7-RNA-polymerase system and evidence for 6α-hydroxylation and D6-testosterone formation. European Journal of Biochemistry 181, 331–336.

Aoyama T. , Yamano S. , Waxman D.J. , Lapenson D.P. , Meyer U.A. , Fischer V. , Tyndale R. , Inaba T. , Kalow W. , Gelboin H.V. , and Gonzalez F.J. (1989). Cytochrome P450 hPCN3, a novel cytochrome P4503A gene product that is differentially expressed in adult human liver; cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporin. Journal of Biological Chemistry 264, 10,388–10,395.

Wiebel F.J. , Lambiotte M. , Singh J. , Summer K.H. , and Wolff T. (1984). Expression of carcinogen-metabolising enzymes in continuous cultures of mammalian cells. In Biochemical Basis of Chemical Carcinogenesis (ed. Greim H. , Jung R. , Kramer M. , Marquardt H. , Oesch F. ), pp. 77–88. New York: Raven Press.

Kiefer F. , and Wiebel F.J. (1989). V79 Chinese hamster cells express cytochrome P450 activity after simultaneous exposure to polycyclic aromatic hydrocarbons and aminophyline. Toxicology Letters 48, 265–273.

Doehmer J. , and Oesch F. (1991). V79 Chinese hamster cells genetically engineered for stable expression of cytochrome P450. Methods in Enzymology 206, 117–124.

Schneider A. , Schmalix W.A. , Siruguri V. , de Groene E.M. , Horbach G.J. , Kleingeist B. , Lang D. , Böcker R. , Belloc C. , Beaune P. , Greim H. , and Doehmer J. (1996). Stable expression of human cytochrome P4503A4 in conjunction with human NADPH-cytochrome P450 oxidoreductase in V79 hamster cells. Archives of Biochemistry and Biophysics 332, 295–304.

Trinidad A.C. , Wu R.W. , Thompson L.H. , and Felton H.S. (1991). Expression of mouse cytochrome P4501A1 cDNA in repair-deficient and repair-proficient CHO cells. Molecular Carcinogenesis 4, 510–518.

Kioussis D. (1992). Oncogenesis and transgenic mice. In Transgenic Mice (ed. Grosveld F. , Kollias G. ), pp. 195–210. London: Academic Press.

Lacave R. , Bens M. , Cartier N. , Vallet V. , Robine S. , Pringault E. , Kahn A. , and Vandewalle A. (1993). Functional properties of proximal tubule cell lines derived from transgenic mice harboring L-pyruvate kinase-SV40 (T) antigen hybrid gene. Journal of Cell Science 104, 705–712.

Voisin T. , Lorinet A-M. , Maoret J-J. , Couvineau A. , and Laburthe M. (1996). G_αi RNA anti-sense expression demonstrates the exclusive coupling of peptide YY receptors to G_i2 proteins in renal proximal tubule cells. Journal of Biological Chemistry 271, 574–580.

Riccaldi D. , Robic D. , Bens M. , Cluzeaud F. , Wu M.S. , Bourbouze R. , and Vandewalle A. (1995). Cultured proximal cells derived from transgenic mouse provide a model to study drug toxicity. Kidney International 48, 722–730.

Rodrigues A.D. (1994). Use of in vitro human metabolism studies in drug development. An industrial perspective. Biochemical Pharmacology 48, 2147–2156.

Remmell R.P. , & Burchell B (1993). Validation and use of cloned, expressed human drug-metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions. Biochemical Pharmacology 46, 559–566.

Glatt H. (1997). Bioactivation of mutagens via sulfation. FASEB Journal 11, 314–321.

Glatt H. , Bartsch I. , Christoph S. , Coughtne M.W.H. , Falany C.N. , Hagen M. , Landsiedel R. , Pabel U. , Phillips D.H. , Seidel A. , and Yamazoe Y. (1997). Sulfotransferase-mediated activation of mutagens, studied using heterologous expression systems. Chemico-Biological Interactions, in press.

Daly A.K. (1996). Molecular basis of polymorphic drug metabolism. Journal of Molecular Medicine 11, 539–553.